0001970123-24-000001.txt : 20241101 0001970123-24-000001.hdr.sgml : 20241101 20241101163421 ACCESSION NUMBER: 0001970123-24-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20241101 DATE AS OF CHANGE: 20241101 EFFECTIVENESS DATE: 20241101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Deerfield Healthcare Innovations Fund III, L.P. CENTRAL INDEX KEY: 0001970123 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-496385 FILM NUMBER: 241419529 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 212-551-1600 MAIL ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 D/A 1 primary_doc.xml X0708 D/A LIVE 0001970123 Deerfield Healthcare Innovations Fund III, L.P. 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY NEW YORK 10010 212-551-1600 DELAWARE None None Limited Partnership true 2023 N/A N/A Deerfield Mgmt HIF III, L.P. 345 Park Avenue South 12th Floor New York NY NEW YORK 10010 Promoter General Partner of the Issuer N/A N/A J.E. Flynn Capital HIF III, LLC 345 Park Avenue South 12th Floor New York NY NEW YORK 10010 Promoter General Partner of the Issuer's General Partner James E. Flynn 345 Park Avenue South 12th Floor New York NY NEW YORK 10010 Executive Officer Promoter President of the General Partner of the Issuer's General Partner Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 true 0001970123-23-000001 2023-11-03 false true true false 0 Indefinite 469633000 Indefinite Includes amounts in respect of Issuer's parallel entity. The general partner reserves the right to offer a greater amount of limited partner interests. false 52 0 true 0 true 0 true The general partner is entitled to a performance allocation. The investment manager is entitled to a management fee. The performance allocation and management fee are fully discussed in the Issuer's confidential offering materials. false Deerfield Healthcare Innovations Fund III, L.P. James E. Flynn James E. Flynn President of the GP of the Issuer's GP 2024-11-01